A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...
15h
FOX54 News Huntsville on MSNKerry Goode: Inspiring one breath at a timePlayers like Kerry Goode. The pride of Hazelwood High School once dreamed of plunging into the endzone and helping his team ...
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a Michigan Medicine-led study suggests.
Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...
Competing in a marathon could be considered quite the task for some, but not for one Amyotrophic Lateral Sclerosis (ALS) ...
Barbara Goodfriend, 83, opted for medical aid in dying after being diagnosed with ALS. The New Jersey widow ended her life in ...
A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.
MAID is currently legal in 10 states and Washington, D.C., but eight other states are considering similar laws this year.
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results